Therapeutic Neuromodulation for Bipolar Disorder-The Case for Biomarker-Driven Treatment Development
- PMID: 33710284
- PMCID: PMC10695405
- DOI: 10.1001/jamanetworkopen.2021.1055
Therapeutic Neuromodulation for Bipolar Disorder-The Case for Biomarker-Driven Treatment Development
Comment on
-
Efficacy of Active vs Sham Intermittent Theta Burst Transcranial Magnetic Stimulation for Patients With Bipolar Depression: A Randomized Clinical Trial.JAMA Netw Open. 2021 Mar 1;4(3):e210963. doi: 10.1001/jamanetworkopen.2021.0963. JAMA Netw Open. 2021. PMID: 33710288 Free PMC article. Clinical Trial.
References
-
- Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet. 2018;391(10131):1683–1692. doi:10.1016/S0140-6736(18)30295-2 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
